ArticleCancer science2018

Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.

Takahito Kawata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.